Merck & Co.'s [11C]L-235 can be used to assess target engagement of cathepsin K inhibitors June 1, 2021
Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo June 1, 2021
Extracellular nicotinamide phosphoribosyltransferase suggested as a viable ARDS therapeutic target May 31, 2021
RSS